Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Ramos, M"'
Autor:
Garcia-Torralba E; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Department of Medicine, Medical School, University of Murcia, Murcia, 30001, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain., Pérez Ramos M; Department of Pathology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain., Ivars Rubio A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Department of Medicine, Medical School, University of Murcia, Murcia, 30001, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain., Navarro Manzano E; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain.; Centro Regional de Hemodonación, Murcia, 30003, Spain., Blaya Boluda N; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Department of Medicine, Medical School, University of Murcia, Murcia, 30001, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain., Lloret Gil M; Department of Medicine, Medical School, University of Murcia, Murcia, 30001, Spain., Aller A; Department of Medicine, Medical School, University of Murcia, Murcia, 30001, Spain., de la Morena Barrio P; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain., García Garre E; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain., Martínez Díaz F; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain.; Department of Pathology, Hospital Universitario Reina Sofía, Murcia, 30003, Spain.; Department of Pathology, Medical School, University of Murcia, Murcia, 30001, Spain., García Molina F; Department of Pathology, Hospital Universitario Reina Sofía, Murcia, 30003, Spain.; Department of Pathology, Medical School, University of Murcia, Murcia, 30001, Spain., Chaves Benito A; Department of Pathology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Department of Pathology, Medical School, University of Murcia, Murcia, 30001, Spain., García-Martínez E; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, 30008, Spain.; Instituto Murciano de Investigación Biosanitaria, IMIB, Murcia, 30120, Spain.; Medical School, Universidad Católica San Antonio, Murcia, 30107, Spain., Ayala de la Peña F; Department of Medical Oncology, School of Medicine, Hospital Universitario Morales Meseguer, University of Murcia, Avda. Marqués de los Vélez, s/n, Murcia, 30008, Spain. frayala@um.es.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (3), pp. 475-485. Date of Electronic Publication: 2024 Mar 07.
Autor:
Kandala S; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Ramos M; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Voith von Voithenberg L; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Diaz-Jimenez A; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Chocarro S; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Keding J; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Sotillo R; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Translational Lung Research Center Heidelberg (TRLC), German Center for Lung Research (DZL), Heidelberg, Germany. Electronic address: r.sotillo@dkfz-heidelberg.de.
Publikováno v:
Cell reports [Cell Rep] 2023 Dec 26; Vol. 42 (12), pp. 113266. Date of Electronic Publication: 2023 Nov 17.
Autor:
Martín M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Servitja S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain., Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Cruz J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez-Tarruella S; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Chacón JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Toledo, Toledo, Spain., Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastian, Spain., Martínez P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain., Miralles JJ; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Jara C; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Aguiar-Bujanda D; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Sep; Vol. 201 (2), pp. 151-159. Date of Electronic Publication: 2023 Jun 20.
Autor:
de la Cruz-Merino L; Department of Medical Oncology, Medicine Department, Virgen Macarena University Hospital, University of Seville, Dr. Fedriani St, No. 3, Seville, 41009, Spain. luis.cruz.sspa@juntadeandalucia.es.; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain. luis.cruz.sspa@juntadeandalucia.es., Gion M; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cruz J; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Alonso-Romero JL; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Clínico Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain., Quiroga V; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Badalona Applied Research Group in Oncology (B-ARGO Group), Catalan Institute of Oncology, Badalona, Spain., Moreno F; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain., Andrés R; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain., Santisteban M; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Clínica Universidad de Navarra, Navarra, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Ramos M; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Centro Oncológico de Galicia, A Coruña, Spain., Holgado E; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital La Luz, Quironsalud, Madrid, Spain., Cortés J; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; International Breast Cancer Center (IBCC), Quiron Group, Barcelona and Madrid, Spain.; Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., López-Miranda E; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cortés A; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Henao F; Department of Medical Oncology, Medicine Department, Virgen Macarena University Hospital, University of Seville, Dr. Fedriani St, No. 3, Seville, 41009, Spain.; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Palazón-Carrión N; Department of Medical Oncology, Medicine Department, Virgen Macarena University Hospital, University of Seville, Dr. Fedriani St, No. 3, Seville, 41009, Spain.; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Rodriguez LM; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Ceballos I; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Soto A; Department of Medical Oncology, Hospital Clínico Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain., Puertes A; Department of Medical Oncology, Hospital Clínico Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain., Casas M; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Benito S; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Chiesa M; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Bezares S; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Caballero R; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain., Jiménez-Cortegana C; Medical Biochemistry and Molecular Biology and Immunology Department, Virgen Macarena University Hospital, University of Seville, Seville, Spain., Sánchez-Margalet V; Medical Biochemistry and Molecular Biology and Immunology Department, Virgen Macarena University Hospital, University of Seville, Seville, Spain., Rojo F; GEICAM Spanish Breast Cancer Group, San Sebastián de los Reyes, Madrid, Spain.; Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERONC-ISCIII, Madrid, Spain.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Dec 03; Vol. 22 (1), pp. 1258. Date of Electronic Publication: 2022 Dec 03.
Autor:
Donat-Vargas C; IMDEA-Food Institute. CEI UAM+CSIC, Madrid, Spain.; Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain.; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Guerrero-Zotano Á; Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain., Lope V; National Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCII), Madrid, Spain., Bermejo B; Medical Oncology Unit, Hospital Clínico, Valencia, Spain., Casas A; Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain., Baena-Cañada JM; Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain.; Instituto de Investigación en Biomedicina de Cádiz (INiBICA), Cádiz, Spain., Antolín S; Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, Coruña, Spain., Sánchez-Rovira P; Medical Oncology Unit, Hospital Universitario de Jaén, Jaén, España., Antón A; Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España., Garcia-Saénz JÁ; Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain., Ramos M; Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain., Muñoz M; Medical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain., de Juan A; Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain., Jara Sánchez C; Medical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain., Chacón JI; Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain., Gil-Gil M; Medical Oncology Unit, Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain., Andrés Conejero R; Medical Oncology Unit, Hospital Clínico Lozano Blesa, Zaragoza, Spain., Llombart A; Medical Oncology Unit, Hospital Arnau de Vilanova, Valencia, Spain., Bezares S; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Fernández de Larrea-Baz N; National Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCII), Madrid, Spain., Pérez-Gómez B; National Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCII), Madrid, Spain., Martín M; Medical Oncology Unit, Instituto de Investigación Sanitaria Gregorio Marañón/Universidad Complutense, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Pollán M; National Center for Epidemiology, Instituto de Salud Carlos III (ISCII), Madrid, Spain. mpollan@isciii.es.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCII), Madrid, Spain. mpollan@isciii.es.
Publikováno v:
European journal of clinical nutrition [Eur J Clin Nutr] 2022 Sep; Vol. 76 (9), pp. 1343-1346. Date of Electronic Publication: 2022 Feb 22.
Autor:
Martín M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. Electronic address: mmartin@geicam.org., Zielinski C; Vienna Cancer Center, Medical University Vienna and Vienna Hospital Association, Vienna, Austria; CECOG, Central European Cooperative Oncology Group, Vienna, Austria., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Virgen Del Rocío, Sevilla, Spain., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Ciruelos EM; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; HM Hospitales Madrid, Spain; SOLTI Group on Breast Cancer Research., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Translational Genomics and Targeted Therapies in Solid Tumours, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria-INCLIVA Valencia, Spain., Margelí M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Badalona Applied Research Group in Oncology (ARGO Group), Institut Catalá D'Oncologia, Hospital Universitari Germans Trias I Pujol, Badalona, Spain., Csöszi T; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelőintezet, Szolnok, Hungary., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón-IISA, Zaragoza, Spain., Turner N; Institute of Cancer Research and Royal Marsden, London, UK., Casas MI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Morales S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Medical Oncology. Hospital Universitario Arnau de Vilanova, Lleida, Spain., Alba E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; UGCI Medical Oncology, Hospitales Regional y Virgen de La Victoria. IBIMA. Málaga, Spain., Calvo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., de la Haba-Rodríguez J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain; Instituto Maimonides de Investigación Biomédica, Hospital Reina Sofía Hospital, Universidad de Córdoba, Córdoba, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Centro Oncológico de Galicia, A Coruña, Spain., Murillo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Clínico de Zaragoza Lozano Blesa, Zaragoza, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Alonso-Romero JL; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Hospital Universitario Virgen de La Arrixaca-IMIB, Murcia, Spain., Sánchez-Rovira P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Oncology Unit, Universitary Hospital Jaén, Spain., Corsaro M; Pfizer Inc., Milan, Italy., Huang X; Pfizer Inc., San Diego, USA., Thallinger C; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncology, Medical University of Vienna, Austria., Kahan Z; CECOG, Central European Cooperative Oncology Group, Vienna, Austria; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Gil-Gil M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Institut Català D'Oncologia (ICO) & IDIBELL, L'Hospitalet, Barcelona, Spain.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jun; Vol. 168, pp. 12-24. Date of Electronic Publication: 2022 Apr 13.
Autor:
García-Sáenz JÁ; Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain.; Centro de Investigación Biomédica en Red CIBERONC-ISCIII, Madrid, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Martínez-Jáñez N; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cubedo R; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jerez Y; Centro de Investigación Biomédica en Red CIBERONC-ISCIII, Madrid, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Fundación de Investigación Biomédica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Lahuerta A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Onkologikoa, Gipuzkoa, Spain., González-Santiago S; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain., Ferrer N; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitari Son Espases, Palma, Spain., Ramos M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Centro Oncológico de Galicia, A Coruña, Spain., Alonso-Romero JL; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain., Antón A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Carrasco E; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Chen J; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Neuwirth R; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Galinsky K; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Vincent S; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Leonard EJ; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Slamon D; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 15; Vol. 28 (6), pp. 1107-1116.
Autor:
Albanell J; Medical Oncology, Hospital Del Mar, IMIM, Barcelona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Pompeu Fabra University, Barcelona, Spain. Electronic address: jalbanell@hospitaldelmar.cat., Martínez MT; Medical Oncology. Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria-INCLIVA, Valencia, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Ramos M; Medical Oncology, Centro Oncológico A Coruña, Coruña, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., O'Connor M; University Hospital Waterford, Waterford, Ireland; Cancer Trials Ireland, Dublin, Ireland., de la Cruz-Merino L; Medical Oncology, Hospital Universitario Virgen de La Macarena, Medicine Department-Universidad de Sevilla, Sevilla, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Santaballa A; Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Martínez-Jañez N; Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Moreno F; Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Fernández I; Medical Oncology, Hospital Álvaro Cunqueiro, Vigo, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Alarcón J; Medical Oncology, Hospital Universitari Son Espases, Palma de Mallorca, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Virizuela JA; Medical Oncology, Hospital Quirónsalud Sagrado Corazón, Sevilla, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., de la Haba-Rodríguez J; Medical Oncology, Instituto Maimónides de Investigación Biomédica, Hospital Reina Sofía, Universidad de Córdoba; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain., Sánchez-Rovira P; Medical Oncology, Hospital Universitario de Jaén, Jaén, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., González-Cortijo L; Medical Oncology, Hospital Universitario Quirónsalud, Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Margelí M; Medical Oncology, B-ARGO Group, Catalan Institute of Oncology, Hospital Universitari Germans Trias I Pujol, Badalona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Sánchez-Muñoz A; Medical Oncology Intercenter Unit, Regional and Virgen de La Victoria University Hospitals, IBIMA, Malaga, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Antón A; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain., Casas M; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Bezares S; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Rojo F; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 161, pp. 26-37. Date of Electronic Publication: 2021 Dec 11.
Autor:
Villarreal-Garza C; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Centro de Cancer de Mama, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Ferrigno AS; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Centro de Cancer de Mama, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Mesa-Chavez F; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Centro de Cancer de Mama, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Platas A; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Departamento de Tumores Mamarios y Departamento de Investigacion, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico., Miaja M; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Centro de Cancer de Mama, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Fonseca A; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Departamento de Tumores Mamarios y Departamento de Investigacion, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico., Cruz-Ramos M; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Departamento de Tumores Mamarios y Departamento de Investigacion, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico., Mohar A; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Departamento de Tumores Mamarios y Departamento de Investigacion, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico., Bargallo-Rocha JE; Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Ciudad de Mexico, Mexico; Departamento de Tumores Mamarios y Departamento de Investigacion, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico., Chapman JW; Public Health Sciences Department and Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada (retired). Electronic address: jachapma@aol.com.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2021 Dec; Vol. 21 (6), pp. e675-e680. Date of Electronic Publication: 2021 Apr 20.
Autor:
Donat-Vargas C; IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain.; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain.; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Guerrero-Zotano Á; Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain., Casas A; Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain., Baena-Cañada JM; Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain.; Instituto de Investigación en Biomedicina de Cádiz (INiBICA), Cádiz, Spain., Lope V; National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Antolín S; Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain., Garcia-Saénz JÁ; Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain., Bermejo B; Medical Oncology Unit, Hospital Clínico, Valencia, Spain., Muñoz M; Medical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain., Ramos M; Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain., de Juan A; Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain., Jara Sánchez C; Medical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain., Sánchez-Rovira P; Medical Oncology Unit, Hospital Universitario de Jaén, Jaén, España., Antón A; Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España., Brunet J; Medical Oncology Department, Institut Català d'Oncologia, IDIBGi, Girona, Spain.; Medical Sciences Department, Universitat de Girona, Girona, Spain., Gavilá J; Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain., Salvador J; Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain., Arriola Arellano E; Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain., Bezares S; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain., Fernández de Larrea-Baz N; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain.; National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Pérez-Gómez B; National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Martín M; Medical Oncology Unit, Instituto de Investigación Sanitaria Gregorio Marañón/Universidad Complutense, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Pollán M; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain. mpollan@isciii.es.; National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain. mpollan@isciii.es.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. mpollan@isciii.es.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Oct; Vol. 125 (8), pp. 1168-1176. Date of Electronic Publication: 2021 Sep 06.